SCHEMBL4107794

SCHEMBL4107794

Fc1cnc(Cl)nc1Nc1ccc2[nH]c(C(F)(F)F)nc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 2/20 0.42
▸ SYK P43405 5/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ROCK2 O75116 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ HPGD P15428 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ TRPA1 O75762 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ BCL6 P41182 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119705 0.87 MEN1 (0.45) CDK1SYKNPSR1HSD17B10HTT
SCHEMBL658909 0.76 STK17A (0.51) SYKAURKA
SCHEMBL339742 0.76 SYK (0.46) CDK1SYKMAPTPOLBAURKA
SCHEMBL654408 0.75 ALDH1A1 (0.47) SYKAURKAALDH1A1BCL6
SCHEMBL3458617 0.75 EGFR (0.49) CDK1SYKROCK2ROCK1AURKA
SCHEMBL655376 0.74 AURKA (0.49) CDK1SYKAURKAALDH1A1BCL6
SCHEMBL657293 0.74 ROCK2 (0.61) SYKROCK2ROCK1
SCHEMBL656017 0.74 SYK (0.60) CDK1SYKROCK2ROCK1
SCHEMBL656737 0.74 SYK (0.55) CDK1SYKAURKATRPA1ALDH1A1
SCHEMBL655569 0.73 STK17A (0.43) SYKAURKABCL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009063240-A1 2,4-DIAMINOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF AURORA KINASE ARROW THERAPEUTICS LIMITED (GB) 2009-05-22 — — WO disclosed
Send feedback